Viewing Study NCT00669318


Ignite Creation Date: 2025-12-25 @ 4:32 AM
Ignite Modification Date: 2025-12-26 @ 3:34 AM
Study NCT ID: NCT00669318
Status: COMPLETED
Last Update Posted: 2014-07-01
First Post: 2008-04-29
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Pentostatin, Alemtuzumab, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Sponsor: Mayo Clinic
Organization: